Seres Therapeutics Inc (MCRB)
0.9206
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.89
-0.03
(-3.32%)
After-Hours: 20:00
Seres Therapeutics Total Assets (Quarterly): 341.26M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 341.26M |
| December 31, 2023 | 358.60M |
| September 30, 2023 | 367.70M |
| June 30, 2023 | 406.39M |
| March 31, 2023 | 270.19M |
| December 31, 2022 | 348.78M |
| September 30, 2022 | 311.87M |
| June 30, 2022 | 273.20M |
| March 31, 2022 | 319.89M |
| December 31, 2021 | 354.86M |
| September 30, 2021 | 396.29M |
| June 30, 2021 | 269.65M |
| March 31, 2021 | 305.70M |
| December 31, 2020 | 342.94M |
| September 30, 2020 | 356.20M |
| June 30, 2020 | 100.68M |
| March 31, 2020 | 110.62M |
| December 31, 2019 | 132.44M |
| September 30, 2019 | 124.15M |
| Date | Value |
|---|---|
| June 30, 2019 | 146.09M |
| March 31, 2019 | 107.04M |
| December 31, 2018 | 120.47M |
| September 30, 2018 | 109.04M |
| June 30, 2018 | 132.95M |
| March 31, 2018 | 159.43M |
| December 31, 2017 | 189.52M |
| September 30, 2017 | 211.88M |
| June 30, 2017 | 216.34M |
| March 31, 2017 | 244.85M |
| December 31, 2016 | 272.65M |
| September 30, 2016 | 297.51M |
| June 30, 2016 | 306.22M |
| March 31, 2016 | 324.47M |
| December 31, 2015 | 216.90M |
| September 30, 2015 | 227.04M |
| June 30, 2015 | 101.28M |
| March 31, 2015 | 108.63M |
| December 31, 2014 | 117.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
100.68M
Minimum
Jun 2020
406.39M
Maximum
Jun 2023
281.87M
Average
315.88M
Median
Total Assets (Quarterly) Benchmarks
| Integra Lifesciences Holdings Corp | 4.078B |
| Nuwellis Inc | 6.662M |
| Axogen Inc | 186.52M |
| Axsome Therapeutics Inc | 545.73M |
| 908 Devices Inc | 189.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 401.00M |
| Shareholders Equity (Quarterly) | -59.74M |